Q1 2022
Released May 4, 2022, after the close
10-Q filed May 5, 2022, 35 days after period end · 0001493152-22-012190
Q1 2022 · 10-Q
Revenue$2.16M$2.16M −21.1% vs Q1 2021−18.1% vs Q4 2021
Net Income-$1.97M-$1.97M N/M vs Q1 2021N/M vs Q4 2021
EPS, diluted—
Gross Profit$1,053,000−33.6%
Operating Income-$1,547,000N/M
Operating Cash Flow-$1,797,000N/M
Free Cash Flowderived-$1,831,000N/M
Margins · derived
Gross margin48.8%−9.2 pt vs Q1 2021
Operating margin-71.7%−34.4 pt vs Q1 2021
Net margin-91.1%−71.5 pt vs Q1 2021
What the release said
The release
Same quarter
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $2.16M | $2.74M | $2.53M | $1.77M |
| Net Income | -$1.97M | -$537.00K | -$1.10M | -$1.35M |
| EPS Diluted | — | -$0.06 | -$0.13 | -$0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR